Suchergebnisse
Intellicheck Q2 Earnings Call Highlights
Key Points
- Interested in Intellicheck, Inc.? Here are five stocks we like better.
- Intellicheck reported solid second-quarter results, with revenue of $5.9 million, net income of $633,000, 91%
Health In Tech Q2 Earnings Call Highlights
Key Points
- Interested in Health In Tech, Inc.? Here are five stocks we like better.
- Q2 revenue fell 13.5% to $8.1 million, which management attributed to policy-recognition timing related to
Genasys Q3 Earnings Call Highlights
Key Points
- Interested in Genasys Inc.? Here are five stocks we like better.
- Revenue fell to $7.3 million from $9.9 million year over year due to temporary supply-chain issues affecting the
Nektar Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in Nektar Therapeutics? Here are five stocks we like better.
- Nektar has started its global Phase III ZENITH AD program for REZPEG in moderate-to-severe atopic dermatitis
Merlin, Inc. Common Stock Q2 Earnings Call Highlights
Key Points
- Interested in Merlin, Inc. Common Stock? Here are five stocks we like better.
- Second-quarter revenue rose to approximately $2.2 million, up $1.2 million sequentially, while Merlin
Mobilicom Q2 Earnings Call Highlights
Key Points
- Interested in Mobilicom Limited Sponsored ADR? Here are five stocks we like better.
- Second-quarter revenue reached approximately $1.2 million, driven by monthly deliveries under a
Midera Food Processing Q2 Earnings Call Highlights
Key Points
- Interested in Midera Food Processing? Here are five stocks we like better.
- Strong second-quarter performance: Net sales rose 13% year over year to $245.4 million, while estimated
Agora Q2 Earnings Call Highlights
Key Points
- Interested in Agora, Inc. Sponsored ADR? Here are five stocks we like better.
- Agora’s Q2 results exceeded guidance: Revenue rose 18% year over year to $40.4 million, GAAP net income